Ropivacaine Uses, Dosage, Side Effects and Interactions
Naropin
Naropin was the first ropivacaine product the FDA approved, in September 1996. An FDA-approved generic with the same active ingredient is listed.
Ropivacaine is an injected numbing medicine (an amide local anesthetic) used by clinicians for anesthesia during surgery and for acute pain control, such as after surgery or during labor.
Quick links
Ask Anything About RopivacaineType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Ropivacaine in Short
- Drug class Amide Local Anesthetic How the FDA classifies it
What it treatsRopivacaine is used in adults to numb part of the body for surgery and to manage acute (short-term) pain. It is given only by trained clinicians. For surgery, it is used for epidural block (including cesarean section), major nerve block and local infiltration (numbing the tissue around the surgical site).
- How you get it Prescription only
- Comes asInjection (around a nerve, into the epidural space, into the tissue at the site)Available strengths
- 150 mg/30 mL
Amount in each mL
- 2 mg/mL
- 7.5 mg/mL
- 10 mg/mL
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
- Generic versionYes, FDA-approved Listed with the FDA, which does not mean every pharmacy stocks it
The Pharmacist’s Take
Ropivacaine (Naropin) is a numbing medicine, an amide local anesthetic, that a trained clinician injects near nerves, around a surgical site or into the epidural space to block pain signals for surgery, labor or recovery; on the U.S. market since about 1996, it is a common choice for epidurals and nerve blocks, and FDA-approved generics are listed. Most people tolerate it well; the side effects seen most are a dip in blood pressure, nausea and itching. The danger is too much reaching the blood, which can affect the nerves and heart, so speak up at once about ringing ears, tingling around the mouth or a metallic taste.
Key Takeaways From the HelloPharmacist Team
- Expect a clinician to inject it or run it as a continuous epidural infusion, with your blood pressure and heart watched.
- Before it is given, mention liver, kidney or heart problems and any past reaction to numbing medicines, since these can change the plan.
- Share your full medicine list; fluvoxamine can raise its blood levels and amiodarone can add to its effects on the heart.
- After an epidural, report leg weakness, numbness or loss of bladder or bowel control that lingers once the numbing should have worn off.
Patient Information Guide for Ropivacaine
What It’s Used For
Ropivacaine is an injected local anesthetic for adults, used for numbing during surgery and for acute pain.
- Surgical anesthesia: epidural block for surgery, including cesarean section
- Surgical anesthesia: major nerve block
- Surgical anesthesia: local infiltration
- Acute pain management: epidural continuous infusion or intermittent bolus, such as after surgery or during labor
- Acute pain management: local infiltration
Naropin and ropivacaine hydrochloride injection labels list these same uses.
How It Works
Ropivacaine belongs to the amino amide class of local anesthetics. It blocks the start and travel of nerve impulses, apparently by making nerves harder to excite and slowing the signal. Thicker, faster nerve fibers are affected differently than thinner ones, so you lose pain first, then temperature, touch, position sense and muscle tone.
Drug Class
Drug Class
- Amide Local Anesthetic
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)- Amide Local Anesthetic
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)None listed for Ropivacaine in the FDA’s index.
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)- Local Anesthesia
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)- Amides
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Amides
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
Ropivacaine is given by a clinician, not taken at home. Routes include epidural, around nerves (perineural) and local infiltration.
- It is given slowly and in small steps, not as one rapid large injection.
- The lowest effective dose and concentration is used.
- The amount depends on the procedure, area numbed, tissue blood supply and how long numbness is needed.
- Food and missed doses do not apply.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Anesthesia for surgery
Adults having surgery with a lumbar epidural · 5 mg Dose 75 to 150 mg
- 15 to 30 mL (75 to 150 mg)
- Onset 15 to 30 min
- Duration 2 to 4 hours
Adults having surgery with a lumbar epidural · 7.5 mg Dose 113 to 188 mg
- 15 to 25 mL (113 to 188 mg)
- Onset 10 to 20 min
- Duration 3 to 5 hours
Adults having surgery with a lumbar epidural · 10 mg Dose 150 to 200 mg
- 15 to 20 mL (150 to 200 mg)
- Onset 10 to 20 min
- Duration 4 to 6 hours
Adults having a cesarean section · 5 mg Dose 100 to 150 mg
- 20 to 30 mL (100 to 150 mg)
- Onset 15 to 25 min
- Duration 2 to 4 hours
Adults having a cesarean section · 7.5 mg Dose 113 to 150 mg
- 15 to 20 mL (113 to 150 mg)
- Onset 10 to 20 min
- Duration 3 to 5 hours
Adults having surgery with a thoracic epidural · 5 mg Dose 25 to 75 mg
- 5 to 15 mL (25 to 75 mg)
- Onset 10 to 20 min
- Duration n/a
Adults having surgery with a thoracic epidural · 7.5 mg Dose 38 to 113 mg
- 5 to 15 mL (38 to 113 mg)
- Onset 10 to 20 min
- Duration n/a
Adults having a major nerve block · 5 mg Dose 175 to 250 mg
- 35 to 50 mL (175 to 250 mg)
- Onset 15 to 30 min
- Duration 5 to 8 hours
Good to know
Dose must be adjusted according to site of administration and patient status
Adults having a major nerve block · 7.5 mg Dose 75 to 300 mg
- 10 to 40 mL (75 to 300 mg)
- Onset 10 to 25 min
- Duration 6 to 10 hours
Good to know
Dose must be adjusted according to site of administration and patient status
Adults having a field block Dose 5 to 200 mg
- 1 to 40 mL (5 to 200 mg)
- Onset 1 to 15 min
- Duration 2 to 6 hours
Pain relief
Women in labor · Initial dose Dose 20 to 40 mg
- 10 to 20 mL (20 to 40 mg)
- Onset 10 to15 min
- Duration 0.5 to 1.5 hours
Women in labor · Continuous infusion Dose 6 to 14 mL/h
- 6 to 14 mL/h (12 to 28 mg/h)
Good to know
Median dose of 21 mg per hour was given over a median of 5.5 hours
Women in labor · Incremental injections (top-up) Dose 10 to 15 mL/h
- 10 to 15 mL/h (20 to 30 mg/h)
Good to know
Median dose of 21 mg per hour was given over a median of 5.5 hours
Side Effects
Most side effects come from the way regional anesthesia affects the body. Common ones in studies include:
Common side effects
- Low blood pressure
- Nausea
- Vomiting
- Slow heart rate
- Fever
- Headache
- Itching
- Back pain
When to get medical help
- Tell your care team right away about ringing in the ears, numbness or tingling around the mouth, a metallic taste, dizziness, blurred vision, tremors, twitching, restlessness or drowsiness. These can be early signs of nervous system toxicity.
- Seek urgent help for chest symptoms, a very slow or irregular heartbeat, or trouble breathing. The drug can affect the heart if too much reaches the blood.
- Report bluish or gray skin color or unusual blood color. These can be signs of methemoglobinemia (a problem with the blood carrying oxygen), which can appear hours later.
- Report signs of an allergic reaction such as hives, swelling of the face or throat, or fainting.
- Report joint pain, stiffness or loss of motion after surgery if a local anesthetic was infused into the joint. This can be chondrolysis (cartilage loss).
- After an epidural, report leg weakness, numbness or loss of bladder or bowel control.
Warnings and Precautions
- Too much drug in the blood can cause seizures, serious heart rhythm problems and cardiac arrest. Accidental injection into a vein is a key cause.
- Only trained clinicians with emergency equipment should give it.
- Methemoglobinemia (blood unable to carry oxygen well) can occur, sometimes hours later.
- Not approved for joint infusions because of cartilage loss (chondrolysis).
- Not for spinal, paracervical, retrobulbar or intravenous regional anesthesia.
- Not recommended when very fast onset is needed.
Interactions
Some medicines can raise ropivacaine's effects or other risks.
- Other amide-type local anesthetics: toxic effects add up.
- Fluvoxamine and other strong CYP1A2 inhibitors: slower clearance and higher levels.
- Ketoconazole: modestly slower clearance.
- Amiodarone and similar heart rhythm drugs: heart effects may add up.
- Nitrates, dapsone, sulfonamides, certain antimalarials, anticonvulsants and acetaminophen: higher methemoglobinemia risk.
Interactions Listed in the FDA-Approved Label
From the Ropivacaine prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Nitrates/nitrites, other local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants and other drugs associated with methemoglobinemiaWhat happensPatients given local anesthetics are at increased risk of methemoglobinemia when exposed to these drugs at the same time.
-
Other local anesthetics or agents structurally related to amide-type local anestheticsWhat happensThe toxic effects of these drugs are additive.What to doUse ropivacaine with caution.
-
Strong CYP1A2 inhibitors such as fluvoxamineWhat happensPlasma clearance of ropivacaine was reduced by 70% with fluvoxamine (25 mg bid for 2 days), leading to increased ropivacaine plasma levels.What to doCaution should be exercised when CYP1A2 inhibitors are coadministered.
-
Drugs metabolized by CYP1A2 such as theophylline and imipramineWhat happensPossible interactions may occur via competitive inhibition.
-
What happensKetoconazole (100 mg bid for 2 days) caused a 15% reduction in in vivo plasma clearance of ropivacaine.
-
Class III antiarrhythmic drugs For example: amiodaroneWhat happensSpecific interaction trials have not been performed.What to doCaution is advised.
Read the label’s full interactions text
7 DRUG INTERACTIONS Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Ropivacaine hydrochloride injection should be used with caution in patients receiving other local anesthetics or agents structurally related to amide-type local anesthetics, since the toxic effects of these drugs are additive. Cytochrome P4501A2 is involved in the formation of 3-hydroxy ropivacaine, the major metabolite. In vivo, the plasma clearance of ropivacaine was reduced by 70% during coadministration of fluvoxamine (25 mg bid for 2 days), a selective and potent CYP1A2 inhibitor. Thus strong inhibitors of cytochrome P4501A2, such as fluvoxamine, given concomitantly during administration of ropivacaine hydrochloride injection, can interact with ropivacaine hydrochloride injection leading to increased ropivacaine plasma levels. Caution should be exercised when CYP1A2 inhibitors are coadministered. Possible interactions with drugs known to be metabolized by CYP1A2 via competitive inhibition such as theophylline and imipramine may also occur.
Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Allergy to ropivacaine or other amide-type local anesthetics: must not use.
- Liver disease: higher risk of toxic levels.
- Kidney problems: higher risk of toxicity.
- Heart disease, heart block, low blood pressure or low blood volume: extra caution.
- G6PD deficiency or methemoglobinemia history, and infants under 6 months: higher methemoglobinemia risk.
- Older or frail patients: lower doses are often needed.
- Pregnancy: crosses the placenta; no human data on birth defect risk.
- Breastfeeding: low levels in milk; no infant problems reported.
- Children: safety and effectiveness not established.
Overdose
Too much ropivacaine, from large doses or accidental injection into a vein or spinal fluid, can cause seizures, breathing problems and serious heart effects. Treatment is to stop the drug at the first sign of toxicity, protect the airway, give oxygen and support breathing and circulation. Treatment is supportive, and seizures are controlled with medicine if needed.
Half-Life and How Your Body Processes It
After epidural injection, ropivacaine is fully absorbed in two phases, a quick one and a slower one that sets how long it lingers. It is about 94% bound to blood proteins and crosses the placenta. The liver breaks it down mainly through CYP1A2, and most is excreted in urine as metabolites, with only about 1% unchanged. The terminal half-life is about 1.8 hours after intravenous dosing and about 4.2 hours after epidural dosing.
Storage
Solutions should be stored at 20ºC to 25°C (68ºF to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) .
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ropivacaine: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Ropivacaine — the kind of thing our pharmacy team would talk through with you at the counter.
What is ropivacaine used for?
How will I get it?
What side effects should I expect?
What should I tell my team right away?
Should I tell you about my other medicines?
Is it safe in pregnancy or breastfeeding?
Is ropivacaine available over the counter?
When was ropivacaine first available?
Who makes ropivacaine?
What is the brand name of ropivacaine?
What is the generic name of Naropin?
What drug class is ropivacaine?
Is there a generic version of ropivacaine?
What strengths does ropivacaine come in?
Is there a ropivacaine shortage?
Where can I read the ropivacaine prescribing information (package insert)?
Is ropivacaine gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Ropivacaine
Skip the scrolling. Ask in your own words and get an answer from Ropivacaine’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Ropivacaine’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Ropivacaine on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, usually within a day.Ropivacaine Forms and Strengths (How It Comes)
Ropivacaine comes in 1 dose form, the injection. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Ropivacaine inactive ingredients by manufacturer.
Injection
How this form is used
- Naropin is used for anesthesia for surgery, including epidural block for cesarean section, major nerve block and local infiltration.
- Naropin is also used for acute pain management, such as epidural infusion after surgery or in labor, and local infiltration.
- Ropivacaine hydrochloride injection carries the same surgical anesthesia and acute pain uses.
- Naropin should be given in small, gradual doses, avoiding rapid injection of a large volume.
- Naropin is not approved for infusion into joints after surgery.
- Ropivacaine hydrochloride injection uses the smallest dose and concentration that works, and the dose varies with the procedure.
Ropivacaine on the U.S. Market: Products, Makers and Brands
How Ropivacaine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
19 companies list 71 Ropivacaine product records with the FDA, mostly as injection; the earliest marketing or approval year on record is 1996. The one brand name in the directory today is Naropin; the rest are generics.
Also listed with the FDA, not a patient dose form: Powder (15) · Unfinished injection, solution (2) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Ropivacaine Is Used (Medicaid Data)
How many Ropivacaine prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Ropivacaine prescribed? Of the 1,682 medications we measure, Ropivacaine ranks #730 by Medicaid prescriptions — more than 57% of them.
Utilization by Ropivacaine product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
30 ML ropivacaine hydrochloride 5 MG/ML Injection Most dispensed
12 of 46 listed NDCs had Medicaid claims. RxNorm 1734475
20 ML ropivacaine hydrochloride 5 MG/ML Injection
6 of 21 listed NDCs had Medicaid claims. RxNorm 1734483
10 ML ropivacaine hydrochloride 2 MG/ML Injection
4 of 12 listed NDCs had Medicaid claims. RxNorm 1734203
20 ML ropivacaine hydrochloride 2 MG/ML Injection
8 of 28 listed NDCs had Medicaid claims. RxNorm 1734207
100 ML ropivacaine hydrochloride 2 MG/ML Injection
3 of 27 listed NDCs had Medicaid claims. RxNorm 1734347
200 ML ropivacaine hydrochloride 2 MG/ML Injection
4 of 24 listed NDCs had Medicaid claims. RxNorm 1734355
10 ML ropivacaine hydrochloride 10 MG/ML Injection
3 of 11 listed NDCs had Medicaid claims. RxNorm 1734090
20 ML ropivacaine hydrochloride 10 MG/ML Injection
3 of 30 listed NDCs had Medicaid claims. RxNorm 1734084
20 ML ropivacaine hydrochloride 7.5 MG/ML Injection
1 of 12 listed NDCs had Medicaid claims. RxNorm 905189
200 ML ropivacaine hydrochloride 5 MG/ML Injection
2 of 5 listed NDCs had Medicaid claims. RxNorm 1734481
100 ML ropivacaine hydrochloride 5 MG/ML Injection
1 of 8 listed NDCs had Medicaid claims. RxNorm 1734479
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 47 of the 224 listed Ropivacaine NDCs had Medicaid claims.
Compare Ropivacaine Products
A representative set of FDA-listed product records for Ropivacaine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| 2 mg/mL | Epidural, Infiltration, Perineural | Amneal Pharmaceuticals LLC × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Epidural, Infiltration, Perineural | Amneal Pharmaceuticals LLC × 2 listings | ANDA | View NDC → |
| 2 mg/mL | Epidural, Infiltration | Anthea Pharma Private Limited | ANDA | View NDC → |
| 5 mg/mL | Epidural, Infiltration, Perineural | Anthea Pharma Private Limited | ANDA | View NDC → |
| 10 mg/mL | Epidural, Infiltration, Perineural | Anthea Pharma Private Limited | ANDA | View NDC → |
| 150 mg/30 mL | Epidural, Infiltration, Perineural | Armas Pharmaceuticals Inc. | ANDA | View NDC → |
| 2 mg/mL | Epidural, Infiltration, Perineural | Baxter Healthcare Corporation | ANDA | View NDC → |
| 2 mg/mL | Epidural, Infiltration | Baxter Healthcare Corporation × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Epidural, Infiltration, Perineural | Baxter Healthcare Corporation × 2 listings | ANDA | View NDC → |
| 10 mg/mL | Epidural, Infiltration, Perineural | Baxter Healthcare Corporation | ANDA | View NDC → |
| 2 mg/mL | Epidural, Infiltration | Caplin Steriles Limited × 2 listings | ANDA | View NDC → |
| 2 mg/mL | Epidural, Infiltration, Perineural | Caplin Steriles Limited | ANDA | View NDC → |
| 5 mg/mL | Epidural, Infiltration, Perineural | Caplin Steriles Limited × 2 listings | ANDA | View NDC → |
| 10 mg/mL | Epidural | Caplin Steriles Limited | ANDA | View NDC → |
| 5 mg/mL | Epidural, Infiltration, Perineural | Civica, Inc. | ANDA | View NDC → |
| 2 mg/mL | Epidural, Infiltration, Perineural | Eugia US LLC × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Epidural, Infiltration, Perineural | Eugia US LLC × 2 listings | ANDA | View NDC → |
| 7.5 mg/mL | Epidural, Perineural | Eugia US LLC | ANDA | View NDC → |
| 10 mg/mL | Epidural | Eugia US LLC × 2 listings | ANDA | View NDC → |
| 2 mg/mL | Epidural, Infiltration | Fresenius Kabi USA, LLC | NDA | View NDC → |
| 2 mg/mL | Epidural, Infiltration, Perineural | Fresenius Kabi Usa, Llc | ANDA | View NDC → |
| 5 mg/mL | Epidural, Infiltration, Perineural | Fresenius Kabi USA, LLC | NDA | View NDC → |
| 7.5 mg/mL | Epidural, Perineural | Fresenius Kabi USA, LLC | NDA | View NDC → |
| 10 mg/mL | Epidural | Fresenius Kabi USA, LLC | NDA | View NDC → |
| 2 mg/mL | Epidural, Infiltration | Gland Pharma Limited × 2 listings | ANDA | View NDC → |
| 2 mg/mL | Epidural, Infiltration | Glenmark Pharmaceuticals Inc., USA × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Epidural, Infiltration, Perineural | Glenmark Pharmaceuticals Inc., USA × 2 listings | ANDA | View NDC → |
| 10 mg/mL | Epidural, Infiltration, Perineural | Glenmark Pharmaceuticals Inc., USA | ANDA | View NDC → |
| 5 mg/mL | Epidural, Infiltration, Perineural | Henry Schein, Inc. | NDA | View NDC → |
| 2 mg/mL | Epidural, Infiltration | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 2 mg/mL | Epidural, Infiltration, Perineural | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Epidural, Infiltration | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 5 mg/mL | Epidural, Infiltration, Perineural | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 7.5 mg/mL | Epidural | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 10 mg/mL | Epidural | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 2 mg/mL | Epidural, Infiltration, Perineural | Meitheal Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Epidural, Infiltration, Perineural | Meitheal Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 7.5 mg/mL | Epidural, Perineural | Meitheal Pharmaceuticals Inc. | ANDA | View NDC → |
| 10 mg/mL | Epidural | Meitheal Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 2 mg/mL | Epidural, Infiltration, Perineural | Mylan Institutional LLC × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Epidural, Infiltration, Perineural | ProPharma Distribution | ANDA | View NDC → |
| 2 mg/mL | Epidural, Infiltration | Sagent Pharmaceuticals | ANDA | View NDC → |
| 5 mg/mL | Epidural, Infiltration | Sagent Pharmaceuticals | ANDA | View NDC → |
| 2 mg/mL | Epidural, Infiltration, Perineural | SOLA Pharmaceuticals, LLC × 2 listings | ANDA | View NDC → |
| 2 mg/mL | Epidural, Infiltration, Perineural | Somerset Therapeutics, LLC × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Epidural, Infiltration, Perineural | Somerset Therapeutics, LLC × 2 listings | ANDA | View NDC → |
| 7.5 mg/mL | Epidural, Perineural | Somerset Therapeutics, LLC | ANDA | View NDC → |
| 10 mg/mL | Epidural | Somerset Therapeutics, LLC × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Epidural, Infiltration, Perineural | Sportpharm LLC × 2 listings | ANDA | View NDC → |
Showing 71 of 71 products — FDA National Drug Code Directory. See every product, package size and price: browse all 71 Ropivacaine NDCs →
Ropivacaine Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Ropivacaine — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Ropivacaine in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Ropivacaine FDA Approval History
How Ropivacaine went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Ropivacaine Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list 2 Ropivacaine recalls since July 2021. One of them is still ongoing and is listed first. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.
- Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose Vials, Rx only, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-286-23;… Lots: Lot #: 6133436, Exp. Date 10/2028 FDA record D-0727-2026 →
- Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL), Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Mehsana, India, , Distributed by: Amneal Pharmaceuticals LLC, Bridgewate… Lots: Lot #'s: AL240003, AL240004, Exp.: 01/31/2026 FDA record D-0402-2025 →
Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Ropivacaine in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 2
- Strengths
- 13
- Forms in current FDA listings
- 2 of 2
RxCUI 35780 -
Dose form (SCDF) InjectionIn current FDA listings
RxCUI 1734083Its 11 strengths (SCD)-
10 mL ropivacaine hydrochloride 10 mg/mL
RxCUI 1734090 -
10 mL ropivacaine hydrochloride 2 mg/mL
RxCUI 1734203 -
20 mL ropivacaine hydrochloride 10 mg/mL
RxCUI 1734084 -
20 mL ropivacaine hydrochloride 2 mg/mL
RxCUI 1734207 -
20 mL ropivacaine hydrochloride 5 mg/mL
RxCUI 1734483 -
20 mL ropivacaine hydrochloride 7.5 mg/mL
RxCUI 905189 -
30 mL ropivacaine hydrochloride 5 mg/mL
RxCUI 1734475 -
100 mL ropivacaine hydrochloride 2 mg/mL
RxCUI 1734347 -
100 mL ropivacaine hydrochloride 5 mg/mL
RxCUI 1734479 -
200 mL ropivacaine hydrochloride 2 mg/mL
RxCUI 1734355 -
200 mL ropivacaine hydrochloride 5 mg/mL
RxCUI 1734481
-
10 mL ropivacaine hydrochloride 10 mg/mL
-
Dose form (SCDF) Prefilled SyringeIn current FDA listings
RxCUI 1996290Its 2 strengths (SCD)-
10 mL ropivacaine hydrochloride 2 mg/mL
RxCUI 1996297 -
10 mL ropivacaine hydrochloride 5 mg/mL
RxCUI 1996291
-
10 mL ropivacaine hydrochloride 2 mg/mL
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Ropivacaine Supply and Shortage Status
Whether Ropivacaine is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
Ropivacaine Brand Names
Ropivacaine has one brand name on record: Naropin. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Ropivacaine: Manufacturers and Labelers
19 companies list Ropivacaine products with the FDA. By number of product records, the largest are Eugia US LLC, Hikma Pharmaceuticals USA Inc., Meitheal Pharmaceuticals Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Ropivacaine Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Fresenius Kabi USA, LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →